Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Fischer

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Journal of Neuromuscular Diseases|May 14, 2023
A Mixed-Method Study Exploring Patient-Experienced and Caregiver-Reported Benefits and Side Effects of Corticosteroid Use in Duchenne Muscular DystrophyRyan Fischer, Katherine Porter, Joanne M Donovan, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 10, 2019
The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care managementYanina Jackson, Ellen Janssen, Ryan Fischer, et al.
Orphanet Journal of Rare Diseases|February 22, 2025
The economic impact of caregiving for individuals with Angelman syndrome in the United States: results from a caregiver surveyJohn Jarvis, Elizabeth Chertavian, Marric Buessing, et al.
Transplantation|July 9, 2020
Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver DiseaseMichelle H Kim, Ailene Nguyen, Mary Lo, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 13, 2022
Health Care Transition for Adolescents and Young Adults With Pediatric-Onset Liver Disease and Transplantation: A Position Paper by the North American Society of Pediatric Gastroenterology, Hepatology, and NutritionJennifer Vittorio, Beverly Kosmach-Park, Lindsay Y King, et al.
Journal of Neuromuscular Diseases|February 16, 2024
Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of DiseaseCraig McDonald, Eric Camino, Rafael Escandon, et al.
Circulation|August 11, 2020
Fontan-Associated Liver Disease: Screening, Management, and Transplant ConsiderationsJuliet Emamaullee, Ali N Zaidi, Thomas Schiano, et al.
Plos One|May 3, 2019
Gene therapy as a potential therapeutic option for Duchenne muscular dystrophy: A qualitative preference study of patients and parentsHolly Landrum Peay, Ryan Fischer, Janice P Tzeng, et al.
Orphanet Journal of Rare Diseases|June 25, 2015
How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug AdministrationPat Furlong, John F P Bridges, Lawrence Charnas, et al.
Chiropractic & Manual Therapies|December 10, 2025
Which lumbar spinal stenosis patients will improve with nonsurgical treatment? A secondary analysis of a randomized controlled trialEric J Roseen, Clair N Smith, Asifa Rahim, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Journal of Neuromuscular Diseases|May 14, 2023
A Mixed-Method Study Exploring Patient-Experienced and Caregiver-Reported Benefits and Side Effects of Corticosteroid Use in Duchenne Muscular DystrophyRyan Fischer, Katherine Porter, Joanne M Donovan, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 10, 2019
The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care managementYanina Jackson, Ellen Janssen, Ryan Fischer, et al.
Orphanet Journal of Rare Diseases|February 22, 2025
The economic impact of caregiving for individuals with Angelman syndrome in the United States: results from a caregiver surveyJohn Jarvis, Elizabeth Chertavian, Marric Buessing, et al.
Transplantation|July 9, 2020
Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver DiseaseMichelle H Kim, Ailene Nguyen, Mary Lo, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 13, 2022
Health Care Transition for Adolescents and Young Adults With Pediatric-Onset Liver Disease and Transplantation: A Position Paper by the North American Society of Pediatric Gastroenterology, Hepatology, and NutritionJennifer Vittorio, Beverly Kosmach-Park, Lindsay Y King, et al.
Journal of Neuromuscular Diseases|February 16, 2024
Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of DiseaseCraig McDonald, Eric Camino, Rafael Escandon, et al.
Circulation|August 11, 2020
Fontan-Associated Liver Disease: Screening, Management, and Transplant ConsiderationsJuliet Emamaullee, Ali N Zaidi, Thomas Schiano, et al.
Plos One|May 3, 2019
Gene therapy as a potential therapeutic option for Duchenne muscular dystrophy: A qualitative preference study of patients and parentsHolly Landrum Peay, Ryan Fischer, Janice P Tzeng, et al.
Orphanet Journal of Rare Diseases|June 25, 2015
How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug AdministrationPat Furlong, John F P Bridges, Lawrence Charnas, et al.
Chiropractic & Manual Therapies|December 10, 2025
Which lumbar spinal stenosis patients will improve with nonsurgical treatment? A secondary analysis of a randomized controlled trialEric J Roseen, Clair N Smith, Asifa Rahim, et al.
Pageof 8